Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION

Contents of the leaflet

  1. Introduction
  2. What Cetirizine Cipla is and what it is used for
  3. What you need to know before you take Cetirizine Cipla
  4. How to take Cetirizine Cipla
  5. Possible side effects
  6. Storage of Cetirizine Cipla
  7. Contents of the pack and other information

Introduction

Package Leaflet: Information for the User

Cetirizine Cipla 1 mg/ml Oral Solution EFG

Cetirizine Dihydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Cetirizine Cipla is and what it is used for
  2. What you need to know before you take Cetirizine Cipla
  3. How to take Cetirizine Cipla
  4. Possible side effects
  5. Storage of Cetirizine Cipla
  6. Contents of the pack and other information

1. What Cetirizine Cipla is and what it is used for

Cetirizine, the active substance of this solution, is an antihistamine. This medicine works by blocking the effect of histamine, which is involved in the development of allergic reactions.

Cetirizine Cipla Oral Solution is used for the treatment in adults and pediatric patients 2 years of age and older who have hay fever (seasonal allergic rhinitis), year-round allergies, such as to dust or pets (perennial allergic rhinitis), and urticaria (hives, itching, and redness of the skin).

Antihistamines like Cetirizine Cipla Oral Solution relieve the symptoms and discomforts associated with these conditions, such as sneezing, runny or itchy nose, nasal stuffiness, itchy or watery eyes, and skin rashes.

You should consult your doctor if your symptoms worsen or do not improve after 3 days.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Cetirizine Cipla

Do not take Cetirizine Cipla

  • If you are allergic to cetirizine or hydroxyzine or any other piperazine derivative (closely related active substances), or to any of the other ingredients of this medicine (listed in section 6).
  • If you have severe kidney disease (severe renal impairment with creatinine clearance below 10 ml/min).
  • If you are breastfeeding.

If you experience any of the above symptoms, talk to your pharmacist.

Warnings and precautions

Consult your doctor or pharmacist before taking Cetirizine Cipla.

If you have kidney problems, consult your doctor; if necessary, you will take a lower dose. Your doctor will determine the new dose.

If you have problems urinating (such as spinal cord or prostate or bladder problems), please consult your doctor.

If you are an epileptic patient or a patient at risk of convulsions, consult your doctor.

No clinically significant interactions have been observed between alcohol (with a blood level of 0.5 per thousand, corresponding to one glass of wine) and the use of cetirizine at the recommended dose. However, there are no safety data available when taking higher doses of cetirizine and alcohol together. Therefore, as with all antihistamines, it is recommended to avoid taking Cetirizine Oral Solution with alcohol.

Children

Do not give this medicine to children under 2 years of age.

Other medicines and Cetirizine Cipla

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Due to the profile of cetirizine, no interactions with other medicines are expected.

Taking Cetirizine Cipla with food, drinks, and alcohol

Avoid alcoholic beverages while taking this medicine.

Food does not affect the absorption of cetirizine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

The use of cetirizine oral solution should be avoided in pregnant women. Accidental use of the medicine in pregnant women does not produce any harmful effect on the fetus. However, the medicine should only be administered if necessary and after consulting with the doctor.

Cetirizine is excreted in breast milk. A risk of adverse reactions in the breastfed infant cannot be excluded. Therefore, you should not take cetirizine oral solution during breastfeeding, unless you have consulted your doctor.

Allergy testing

If you are going to have an allergy test, tell your doctor if you should stop taking the oral solution of cetirizine dihydrochloride for several days before the test. This medicine may affect the results of allergy tests.

Driving and using machines

Clinical studies have not shown evidence that cetirizine produces alterations in attention, decreased ability to react, and ability to drive at the recommended dose.

You should carefully observe your response after taking cetirizine oral solution if you intend to drive, engage in potentially hazardous activities, or use machinery. Do not exceed the recommended dose.

Cetirizine Cipla Oral Solution contains sorbitol, sodium, methyl parahydroxybenzoate, and propyl parahydroxybenzoate.

  • This medicine contains 500 mg of sorbitol in each ml of solution, equivalent to 500 mg/ml.
  • Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which the patient cannot break down fructose, consult your doctor before taking this medicine.
  • Sorbitol may cause gastrointestinal upset and a mild laxative effect.
  • The oral solution contains the preservatives methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216), which may cause allergic reactions (possibly delayed).
  • This medicine contains less than 1 mmol of sodium (23 mg) per ml; i.e., it is essentially "sodium-free".

3. How to take Cetirizine Cipla

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Remember that the solution can be swallowed as is.

The dose should be measured using the measuring spoon included with this pack. The spoon has measurement marks that allow you to choose either 2.5 ml (half a spoon) or 5 ml (one whole spoon):

Metal spoon with oval shape and long handle outlined in black and white

Do not take or administer more cetirizine oral solution than the amounts shown below.

If you do not feel better within a few days, consult your doctor.

The recommended dose is:

Children from 2 to 6 years:

2.5 mg twice a day: 2.5 ml of oral solution (half a spoon) twice a day.

Children from 6 to 12 years:

5 mg twice a day: 5 ml of oral solution (one spoon) twice a day.

Adults and adolescents over 12 years of age:

10 mg once a day: 10 ml of oral solution (2 spoons) once a day.

Use in children

Cetirizine oral solution is not suitable for children under 2 years of age.

Renal impairment

Patients with moderate renal impairment are recommended to take 5 mg once a day.

If you have severe kidney disease, please contact your doctor or pharmacist, who may adjust the dose accordingly. If your child has kidney disease, please contact your doctor or pharmacist, who may adjust the dose according to your child's needs.

If you notice that the effect of cetirizine oral solution is too weak or too strong, consult your doctor.

Method of administration

For oral use.

Duration of treatment

The duration of treatment depends on the type, duration, and course of your complaints. Consult your doctor or pharmacist.

If you take more Cetirizine Cipla than you should

If you have accidentally taken more Cetirizine Cipla than the recommended or prescribed dose, consult your doctor immediately. Your doctor will decide what measures to take if necessary.

In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone: 91 562 04 20. Remember to bring the pack with you.

After an overdose, the adverse effects described in section 4 may occur with greater intensity. The following adverse effects have been reported:

confusion,

diarrhea,

dizziness,

fatigue,

headache,

weakness,

pupil dilation,

tingling,

irritation,

sedation,

somnolence,

stupor,

abnormal increase in heart rate,

tremors,

urinary retention.

If you forget to take Cetirizine Cipla

If you forget to take a dose, you should take one as soon as you remember, but you must wait at least 24 hours before taking the next dose.

Do not take a double dose to make up for forgotten doses.

If you stop taking Cetirizine Cipla

On rare occasions, itching and/or hives may reappear if you stop taking cetirizine oral solution.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects are very rare, but you must stop taking the medicine and consult your doctor immediately if you notice any of the following symptoms:

  • A severe allergic reaction, including skin rash, itching, and fever, throat inflammation, face, eyelids, or lip swelling. This reaction may start soon after you start taking the medicine or could start later.

The following side effects have also been reported.

Common side effects(may affect up to 1 in 10 people)

  • Fatigue, somnolence, abdominal pain,
  • headache, dizziness,
  • dry mouth, sore throat,
  • nausea, cold-like symptoms (only in children).
  • diarrhea (only in children),

Uncommon side effects(may affect up to 1 in 100 people)

  • Itching and rash, tingling in hands and feet,
  • diarrhea, feeling agitated.
  • feeling weak or unwell,
    • abdominal pain

Rare side effects(may affect up to 1 in 1,000 people)

  • rapid heartbeat,
  • edema (generalized swelling due to water retention),
  • abnormal liver function test results (your doctor will know what to do),
  • seizures,
  • weight gain,
  • aggression, confusion, depression, hallucinations (hearing or seeing things), sleep disturbances.

Very rare side effects(may affect up to 1 in 10,000 people)

  • low platelet count in the blood
  • blurred vision, difficulty concentrating
  • eye rotation
  • bad taste in the mouth,
  • fainting,
  • bedwetting, pain and/or difficulty urinating,
  • unusual bleeding or bruising,
  • tremors, tics,
  • involuntary movements and/or jerking of the limbs,
  • muscle spasms in the neck and shoulders,
    • drug rash (appearance of red or scaly skin at the same site after taking this medicine).

Side effects with unknown frequency(frequency cannot be estimated from the available data)

  • increased appetite,
  • vertigo,
  • suicidal thoughts (recurring thoughts of suicide or concern about suicide), nightmares
  • urinary retention (inability to fully empty the bladder)..
  • liver inflammation (hepatitis).
    • memory loss, memory impairment
    • joint pain
    • acute generalized exanthematous pustulosis (a red and scaly rash with bumps under the skin and blisters).

Some cases of memory loss and/or impairment have also been reported.

In very rare cases, people have thought about committing suicide, and if you feel this way, stop taking the oral solution and go see your doctor.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Cetirizine Cipla

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the bottle, after EXP. The expiry date is the last day of the month shown.

Do not use after 6 months from the opening of the bottle.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Cetirizine Cipla

  • The active substance is cetirizine dihydrochloride. Each ml of oral solution contains 1 mg of cetirizine dihydrochloride.
  • The other ingredients are:

methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), 70% non-crystallizing sorbitol solution (E420), glycerol, trisodium citrate (sodium citrate), citric acid, propylene glycol, monoammonium glycyrrhizinate, purified water, pineapple flavor No. 1 (012080), and sweet orange flavor (SC406296).

Appearance of the product and pack contents

Cetirizine Cipla Oral Solution is a clear, colorless, flavored solution.

Cetirizine Cipla 1 mg/ml Oral Solution is packaged in a 200 ml amber glass or polyethylene terephthalate bottle, with a child-resistant cap and a measuring spoon with a CE mark of 2.5 ml / 5 ml of transparent plastic.

Marketing authorization holder and manufacturer

Cipla Europe NV

De Keyserlei 58-60

Box-19, 2018

Antwerp, Belgium

You can request more information about this medicine by contacting the local representative of the marketing authorization holder

Cipla Europe NV, Spanish branch

C/Guzmán el Bueno, 133 Edif Britannia

28003, Madrid

This medicine is authorized in the Member States of the European Economic Area under the following names:

Portugal: Cetirizine Cipla, 1 mg/ml, oral solution

Ireland: Anti-Hist Allergy 1 mg/ml Oral Solution

Spain: Cetirizine Cipla 1 mg/ml oral solution EFG

Date of last revision of this leaflet:September 2024

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

  • CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION
    Image: AEMPS – CIMA
  • Country of registration
  • Dosage form
    ORAL SOLUTION/SUSPENSION, 1 mg/ml
  • ATC code
    R06AE07
  • Average pharmacy price
    3.51 EUR
  • Active substance
  • Prescription required
    Yes
  • Manufacturer
  • Composition
    SOLUCION DE SORBITOL 70% (50,00 % P/V mg), PARAHIDROXIBENZOATO DE METILO (E-218) (0,20 % P/V mg), PARAHIDROXIBENZOATO DE PROPILO (0,02 % P/V mg), GLICEROL (E 422) (10,00 % P/V mg), CITRATO DE SODIO (E-331) (0,12 % P/V mg), PROPILENGLICOL (10,00 % P/V mg), CITRATO DE SODIO (E-331) (C.S.P AJUSTE PH % P/V mg)
  • Alternatives to CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION
    ALERCINA 10 mg TABLETS
    Dosage form: TABLET, 10 mg cetirizine dihydrochloride
    Active substance: cetirizine
    Prescription not required
    Dosage form: ORAL SOLUTION/SUSPENSION, 1 mg cetirizine dihydrochloride/ml
    Active substance: cetirizine
    Manufacturer: Retrain, S.A.U.
    Prescription required
    Dosage form: TABLET, 10 mg cetirizine dihydrochloride
    Active substance: cetirizine
    Manufacturer: Retrain, S.A.U.
    Prescription required

Online doctors for CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION

Discuss questions about CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION is cetirizine. This information helps identify medicines with the same composition but different brand names.

The average pharmacy price for CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION is around 3.51 EUR. Prices may vary depending on the manufacturer and dosage form.

CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION is manufactured by Cipla Europe. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Pulmonologists, Allergists, ENT doctors, General medicine doctors, Anaesthesiologists may assess whether CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, CETIRIZINE CIPLA 1 mg/ml ORAL SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (cetirizine) include ALERCINA 10 mg TABLETS, ALERLISIN 1 mg/ml ORAL SOLUTION, ALERLISIN 10 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media